Dent J A, Galbusera M, Ruggeri Z M
Roon Research Center for Arteriosclerosis and Thrombosis, Scripps Clinic, La Jolla, California 92037.
J Clin Invest. 1991 Sep;88(3):774-82. doi: 10.1172/JCI115376.
In this report we demonstrate that proteolytic cleavage of the constituent subunit is one of the causes determining the heterogeneous size distribution of plasma von Willebrand factor (vWf) multimers. As shown by two-dimensional nonreduced/reduced agarose/polyacrylamide gel electrophoresis, the structure of circulating vWf molecules may deviate from that represented by assemblage of a variable number of identical subunits. Indeed, even though the largest multimers in normal plasma appear to be composed predominantly of intact 225-kD subunits, those of intermediate and smaller size contain also 189-, 176-, and 140-kD proteolytic fragments. Different subunit composition patterns are repeated regularly in multimers of increasing molecular mass, yielding series of bands with similar structure. One of these series consists of molecules without evidence of proteolytic fragmentation, and its smallest member appears to be a dimer of 225-kD subunits. Type IIA von Willebrand disease, characterized by absence of the largest multimers, displays a pattern wherein the fragments of 176 and 140 kD are relatively increased, that of 189 kD is markedly decreased or absent, but the composition of individual multimers is otherwise similar to that of species seen also in normal plasma. In contrast to those in the circulation, all normal platelet vWf multimers contain only intact subunit. These results suggest that proteolytic cleavage of plasma vWf subunits occurs after release from cellular sites, whereas platelet vWf stored in alpha-granules is protected from proteolysis. These findings provide information that may be relevant for understanding the normal processing of vWf multimers and for elucidating the pathogenesis of some of the congenital and acquired structural abnormalities of this molecule.
在本报告中,我们证明了组成亚基的蛋白水解切割是决定血浆血管性血友病因子(vWf)多聚体大小分布不均一性的原因之一。二维非还原/还原琼脂糖/聚丙烯酰胺凝胶电泳显示,循环中的vWf分子结构可能与由可变数量相同亚基组装而成的结构不同。实际上,尽管正常血浆中最大的多聚体似乎主要由完整的225-kD亚基组成,但中等大小和较小的多聚体中也含有189-kD、176-kD和140-kD的蛋白水解片段。不同的亚基组成模式在分子量不断增加的多聚体中规律重复,产生一系列结构相似的条带。其中一个系列由无蛋白水解片段证据的分子组成,其最小成员似乎是225-kD亚基的二聚体。以缺乏最大多聚体为特征的IIA型血管性血友病显示出一种模式,其中176-kD和140-kD的片段相对增加,189-kD的片段明显减少或缺失,但单个多聚体的组成在其他方面与正常血浆中的类似。与循环中的情况相反,所有正常血小板vWf多聚体仅包含完整的亚基。这些结果表明,血浆vWf亚基的蛋白水解切割发生在从细胞部位释放之后,而储存在α颗粒中的血小板vWf受到蛋白水解的保护。这些发现为理解vWf多聚体的正常加工过程以及阐明该分子某些先天性和获得性结构异常的发病机制提供了相关信息。